We are live on
!
Find out more
PE
Point72 Europe Portfolio holdings
AUM
$2.04B
1-Year Est. Return
25.99%
This Fund
S&P 500
This Quarter
Est. Return
+12.06%
1 Year Est. Return
+25.99%
3 Year Est. Return
+95.43%
5 Year Est. Return
+195.42%
10 Year Est. Return
–
AUM
$798M
AUM Growth
-$833M
(-51%)
Cap. Flow
-$910M
Cap. Flow
% of AUM
-114.07%
Top 10 Holdings %
Top 10 Hldgs %
29.61%
Holding
458
New
367
Increased
26
Reduced
24
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$19.7M |
| 2 |
Maravai LifeSciences
MRVI
|
+$16.8M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$14.3M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$12.4M |
| 5 |
Chevron
CVX
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cenovus Energy
CVE
|
+$36.3M |
| 2 |
Molson Coors Class B
TAP
|
+$26.6M |
| 3 |
Estee Lauder
EL
|
+$24.8M |
| 4 |
International Flavors & Fragrances
IFF
|
+$15.4M |
| 5 |
DraftKings
DKNG
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.66% |
| 2 | Healthcare | 34.88% |
| 3 | Technology | 10.11% |
| 4 | Energy | 3.74% |
| 5 | Consumer Staples | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Integra LifeSciences
IART
$1.45B
| $31.3M | 3.93% |
719,663
+255,201
| +55% | +$10M |
|
2
Bank of America
BAC
$426B
| $27.2M | 3.41% |
808,461
+150,635
| +23% | +$4.39M |
|
3
Medtronic
MDT
$105B
| $25.5M | 3.19% |
309,484
+44,642
| +17% | +$3.4M |
|
|
DFS
4
DELISTED
Discover Financial Services
DFS
| $24.3M | 3.04% |
215,964
+52,733
| +32% | +$4.87M |
|
5
Qiagen
QGEN
$8.57B
| $22.5M | 2.82% |
489,107
+47,414
| +11% | +$2.02M |
|
6
Procept Biorobotics
PRCT
$989M
| $22.2M | 2.78% |
530,071
+123,800
| +30% | +$4.22M |
|
|
NARI
7
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $21.6M | 2.7% |
332,202
+158,997
| +92% | +$9.57M |
|
8
Coca-Cola Europacific Partners
CCEP
$45.9B
| $21.4M | 2.68% |
320,061
+171,297
| +115% | +$10.5M |
|
9
KKR & Co
KKR
$85.4B
| $20.8M | 2.61% |
250,957
+158,657
| +172% | +$10.7M |
|
|
10
Becton Dickinson
BDX
$42.3B
| $19.5M | 2.44% |
+79,987
| New | +$19.7M |
|
11
Baxter International
BAX
$11.1B
| $19.5M | 2.44% |
503,731
+100,631
| +25% | +$3.56M |
|
12
Option Care Health
OPCH
$3.29B
| $19.4M | 2.43% |
575,005
-67,146
| -10% | -$2.06M |
|
|
13
Maravai LifeSciences
MRVI
$1.05B
| $17.1M | 2.14% |
+2,604,487
| New | +$16.8M |
|
|
SWAV
14
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $14.4M | 1.81% |
+75,690
| New | +$14.3M |
|
|
15
Bio-Rad Laboratories Class A
BIO
$8.4B
| $12.7M | 1.6% |
+39,449
| New | +$12.4M |
|
|
SCHW
16
Charles Schwab
SCHW
$177B
| $12.2M | 1.52% |
176,640
+84,240
| +91% | +$4.87M |
|
17
Wells Fargo
WFC
$260B
| $11.9M | 1.49% |
+242,114
| New | +$10.4M |
|
|
18
Chevron
CVX
$392B
| $11.4M | 1.43% |
+76,432
| New | +$11.6M |
|
19
Corebridge Financial
CRBG
$13.8B
| $11.2M | 1.4% |
+515,767
| New | +$10.6M |
|
20
American International
AIG
$41.7B
| $10.8M | 1.35% |
159,430
+46,423
| +41% | +$2.96M |
|
21
ASML
ASML
$687B
| $10.3M | 1.29% |
+13,600
| New | +$8.98M |
|
22
Bruker
BRKR
$9.42B
| $9.85M | 1.23% |
+134,000
| New | +$8.59M |
|
23
Moody's
MCO
$82.8B
| $9.8M | 1.23% |
25,095
+8,995
| +56% | +$3.13M |
|
24
Morgan Stanley
MS
$336B
| $9.64M | 1.21% |
+103,360
| New | +$8.27M |
|
25
McKesson
MCK
$95.9B
| $9.59M | 1.2% |
20,723
-5,102
| -20% | -$2.32M |
|
Similar funds
PH
AF
CCA
PHK
TAM
FSC
CCB
LNWWM
Point72 Europe's Q4 2023 Portfolio in Review
As of Q4 2023, Point72 Europe held 458 positions worth $798M, down 51% from $1.63B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Point72 Europe withdrew a net $910M in Q4 2023, closing 41 positions and reducing 24 holdings. Its most notable exit was Cenovus Energy, an estimated $36.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Point72 Europe opened a new position in Becton Dickinson worth $19.5M.
- Point72 Europe's largest Q4 2023 buy was Becton Dickinson: 79,987 shares worth $19.5M.
- Point72 Europe added most to KKR & Co in Q4 2023, an estimated $10.7M increase.
- Point72 Europe's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.4M.
- Point72 Europe fully exited Cenovus Energy in Q4 2023, selling an estimated $36.3M.
- Point72 Europe's ten largest holdings make up 30% of its $798M portfolio in Q4 2023.
- Point72 Europe opened 367 new positions and closed 41 in Q4 2023.
- Point72 Europe's portfolio value fell 51% quarter-over-quarter to $798M.
Based on Point72 Europe's 13F filing for Q4 2023, filed 14 Feb 2024.